Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S.; Tandem’s Control-IQ™ hybrid closed-loop ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

Tandem Diabetes Care has announced its Tandem t:slim X2 insulin pump is now compatible with Abbott’s FreeStyle Libre 3 Plus ...

The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin.

Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States Tandem continues to build its technology ecosystem to ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

The t:slim X2 pump is already approved for use with several U-100 insulins, including Humalog and Novolog/NovoRapid globally, as well as Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart ...

SAN DIEGO, September 19, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control ...

Abbott (NYSE: ABT), the global health care company, and Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the t:slim X2 ...

Tandem Diabetes Care, Inc. and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t: slim X2™ insulin pump users can now access full ...

MARKHAM, Ontario — Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ insulin pump ...